DongKook Pharmaceutical Co., Ltd. 086450.KQ Stock
DongKook Pharmaceutical Co., Ltd. Price Chart
DongKook Pharmaceutical Co., Ltd. 086450.KQ Financial and Trading Overview
| DongKook Pharmaceutical Co., Ltd. stock price | 15990 KRW |
| Previous Close | 15020 KRW |
| Open | 15030 KRW |
| Bid | 15020 KRW x 0 |
| Ask | 15050 KRW x 0 |
| Day's Range | 15000 - 15190 KRW |
| 52 Week Range | 14510 - 20550 KRW |
| Volume | 106.76K KRW |
| Avg. Volume | 96.28K KRW |
| Market Cap | 132.02B KRW |
| Beta (5Y Monthly) | 0.918769 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22667 KRW |
086450.KQ Valuation Measures
| Enterprise Value | 737.55B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.20444751 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.142 |
| Enterprise Value/EBITDA | 8.18 |
Trading Information
DongKook Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.918769 |
| 52-Week Change | -21.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 20550 KRW |
| 52 Week Low | 14510 KRW |
| 50-Day Moving Average | 15558 KRW |
| 200-Day Moving Average | 16259.65 KRW |
086450.KQ Share Statistics
| Avg. Volume (3 month) | 96.28K KRW |
| Avg. Daily Volume (10-Days) | 99.97K KRW |
| Shares Outstanding | 8.79M |
| Float | 23.81M |
| Short Ratio | N/A |
| % Held by Insiders | 45.31% |
| % Held by Institutions | 22.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 9.12% |
| Operating Margin (ttm) | 11.07% |
| Gross Margin | 58.03% |
| EBITDA Margin | 13.96% |
Management Effectiveness
| Return on Assets (ttm) | 6.05% |
| Return on Equity (ttm) | 12.05% |
Income Statement
| Revenue (ttm) | 645.74B KRW |
| Revenue Per Share (ttm) | 14692.16 KRW |
| Quarterly Revenue Growth (yoy) | 10.10% |
| Gross Profit (ttm) | 349.92B KRW |
| EBITDA | 90.16B KRW |
| Net Income Avi to Common (ttm) | 58.94B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 39.30% |
Balance Sheet
| Total Cash (mrq) | 104.62B KRW |
| Total Cash Per Share (mrq) | 2380.12 KRW |
| Total Debt (mrq) | 66.08B KRW |
| Total Debt/Equity (mrq) | 12.21 KRW |
| Current Ratio (mrq) | 2.092 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 45.74B KRW |
| Levered Free Cash Flow (ttm) | -18593169408 KRW |
Profile of DongKook Pharmaceutical Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 7, Teheran-ro 108-gil |
| ZIP | N/A |
| Phone | 82 2 2191 9800 |
| Website | https://www.dkpharm.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | 1092 |
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
Q&A For DongKook Pharmaceutical Co., Ltd. Stock
What is a current 086450.KQ stock price?
DongKook Pharmaceutical Co., Ltd. 086450.KQ stock price today per share is 15990 KRW.
How to purchase DongKook Pharmaceutical Co., Ltd. stock?
You can buy 086450.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DongKook Pharmaceutical Co., Ltd.?
The stock symbol or ticker of DongKook Pharmaceutical Co., Ltd. is 086450.KQ.
How many shares does DongKook Pharmaceutical Co., Ltd. have in circulation?
The max supply of DongKook Pharmaceutical Co., Ltd. shares is 43.96M.
What is DongKook Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
DongKook Pharmaceutical Co., Ltd. PE Ratio is now.
What was DongKook Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
DongKook Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.